How to buy Novan stock (NOVN)

Novan is a pharmaceuticals business based in the US. Novan shares (NOVN) are listed on the NASDAQ and all prices are listed in US Dollars. Novan employs 90 staff and has a trailing 12-month revenue of around $24.9 million.

Our top picks for where to buy Novan stock

Buy Novan stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Novan stock price (NASDAQ: NOVN)

Use our graph to track the performance of NOVN stocks over time.

Novan shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.50
200-day moving average more info button	$1.08
Wall St. target price	$15.50
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.84

Is it a good time to buy Novan stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Novan financials

Revenue TTM	$24.9 million
Gross profit TTM	$313,000
Return on assets TTM	-25.84%
Return on equity TTM	-2098.89%
Profit margin	-128.61%
Book value	$-0.10
Market Capitalization more info button	$2.6 million

TTM: trailing 12 months

Novan share dividends

We're not expecting Novan to pay a dividend over the next 12 months.

Have Novan's shares ever split?

Novan's shares were split on a 1:10 basis on 25 May 2021 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Novan shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Novan shares which in turn could have impacted Novan's share price.

Novan share price volatility

Over the last 12 months, Novan's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Novan's is -0.0434. This would suggest that Novan's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Novan has bucked the trend.

Novan overview

Novan, Inc. , a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co. , Ltd.

Frequently asked questions

What percentage of Novan is owned by insiders or institutions?
Currently 0.869% of Novan shares are held by insiders and 14.927% by institutions. How many people work for Novan?
Latest data suggests 90 work at Novan. When does the fiscal year end for Novan?
Novan's fiscal year ends in December. Where is Novan based?
Novan's address is: 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 What is Novan's ISIN number?
Novan's international securities identification number is: US66988N2053 What is Novan's CUSIP number?
Novan's Committee on Uniform Securities Identification Procedures number is: 66988N106